This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2011 Oct 17:18 Suppl 1:S17-25.

doi: 10.1530/ERC-10-0280. Print 2011 Oct.

Circulating biomarkers in gastroenteropancreatic neuroendocrine tumours

Affiliations

PMID: 22005113
DOI: 10.1530/ERC-10-0280

Review

Circulating biomarkers in gastroenteropancreatic neuroendocrine tumours

Kjell Oberg. Endocr Relat Cancer. 2011.

. 2011 Oct 17:18 Suppl 1:S17-25.

doi: 10.1530/ERC-10-0280. Print 2011 Oct.

Author

Affiliation

¹ Department of Endocrine Oncology, University Hospital, Entrance 78, SE-751 85 Uppsala, Sweden. kjell.oberg@medsci.uu.se

PMID: 22005113
DOI: 10.1530/ERC-10-0280

No abstract available

PubMed Disclaimer

Similar articles

Management of pancreatic neuroendocrine tumors.
Dabizzi E, Panossian A, Raimondo M. Dabizzi E, et al. Minerva Gastroenterol Dietol. 2010 Dec;56(4):467-79. Minerva Gastroenterol Dietol. 2010. PMID: 21139544 Review.
[Advances of circulating biomarkers in gastroenteropancreatic neuroendocrine neoplasms].
Chen L, Chen M, Chen J. Chen L, et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Mar 25;20(3):357-360. Zhonghua Wei Chang Wai Ke Za Zhi. 2017. PMID: 28338171 Review. Chinese.
Is the combination of chromogranin A and pancreatic polypeptide serum determinations of interest in the diagnosis and follow-up of gastro-entero-pancreatic neuroendocrine tumours?
Walter T, Chardon L, Chopin-laly X, Raverot V, Caffin AG, Chayvialle JA, Scoazec JY, Lombard-Bohas C. Walter T, et al. Eur J Cancer. 2012 Aug;48(12):1766-73. doi: 10.1016/j.ejca.2011.11.005. Epub 2011 Nov 29. Eur J Cancer. 2012. PMID: 22133573
Prognostic and predictive biomarkers in gastroenteropancreatic neuroendocrine tumors.
Stevenson R, Libutti SK, Saif MW. Stevenson R, et al. JOP. 2013 Mar 10;14(2):155-7. doi: 10.6092/1590-8577/1472. JOP. 2013. PMID: 23474561 Review.
The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors.
Lawrence B, Gustafsson BI, Kidd M, Pavel M, Svejda B, Modlin IM. Lawrence B, et al. Endocrinol Metab Clin North Am. 2011 Mar;40(1):111-34, viii. doi: 10.1016/j.ecl.2010.12.001. Endocrinol Metab Clin North Am. 2011. PMID: 21349414 Review.

See all similar articles

Cited by

The treatment of hyperinsulinemic hypoglycaemia in adults: an update.
Davi MV, Pia A, Guarnotta V, Pizza G, Colao A, Faggiano A; NIKE Group. Davi MV, et al. J Endocrinol Invest. 2017 Jan;40(1):9-20. doi: 10.1007/s40618-016-0536-3. Epub 2016 Sep 13. J Endocrinol Invest. 2017. PMID: 27624297 Review.
Development and Validation of Novel Nomograms Using Serum Tumor Markers for the Prediction of Preoperative Histologic Grades in Gastroenteropancreatic Neuroendocrine Tumors.
Li Y, Wu ZQ, Xu Q, Goyal H, Xu HG. Li Y, et al. Front Oncol. 2021 May 24;11:681149. doi: 10.3389/fonc.2021.681149. eCollection 2021. Front Oncol. 2021. PMID: 34109127 Free PMC article.
The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors.
Howe JR, Merchant NB, Conrad C, Keutgen XM, Hallet J, Drebin JA, Minter RM, Lairmore TC, Tseng JF, Zeh HJ, Libutti SK, Singh G, Lee JE, Hope TA, Kim MK, Menda Y, Halfdanarson TR, Chan JA, Pommier RF. Howe JR, et al. Pancreas. 2020 Jan;49(1):1-33. doi: 10.1097/MPA.0000000000001454. Pancreas. 2020. PMID: 31856076 Free PMC article.
Chromogranin A: From Laboratory to Clinical Aspects of Patients with Neuroendocrine Tumors.
Di Giacinto P, Rota F, Rizza L, Campana D, Isidori A, Lania A, Lenzi A, Zuppi P, Baldelli R. Di Giacinto P, et al. Int J Endocrinol. 2018 Jul 2;2018:8126087. doi: 10.1155/2018/8126087. eCollection 2018. Int J Endocrinol. 2018. PMID: 30057604 Free PMC article. Review.
Role of chromogranin A-derived fragments after resection of nonfunctioning pancreatic neuroendocrine tumors.
Andreasi V, Partelli S, Manzoni MF, Muffatti F, Di Filippo L, Crippa S, Corti A, Falconi M. Andreasi V, et al. J Endocrinol Invest. 2022 Jun;45(6):1209-1217. doi: 10.1007/s40618-022-01750-5. Epub 2022 Feb 5. J Endocrinol Invest. 2022. PMID: 35122631

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Sheridan PubFactory
Medical
- MedlinePlus Health Information